Back to Trades
Song Wenru
EVPHead of R&DCIK 0002143140
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Song Wenru, EVP, Head of R&D, accounts for 1 disclosed filing worth $0, all concentrated in Jasper Therapeutics, Inc. (JSPR), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.